Drug profile · INN
nirsevimab-alip
BEYFORTUS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
nirsevimab-alip (BEYFORTUS) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN nirsevimab-alip
Brand BEYFORTUS
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is nirsevimab-alip?
nirsevimab-alip (BEYFORTUS) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for nirsevimab-alip?
BEYFORTUS is a marketed brand name for nirsevimab-alip. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nirsevimab-alip?
nirsevimab-alip has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.